Novo Nordisk Overview

  • Service
  • Lender

  • Year Founded
  • 1923

Year Founded

  • Professionals
  • 42,000

Professionals

  • Financed Companies
  • 1

  • Financings
  • 2

Novo Nordisk General Information

Description

Novo Nordisk is a global healthcare company which Produces and distributes of insulin and other diabetes drugs. The company develops and distributes insulin and other medical products which are specifically used to treat diabetes.

Contact Information

Formerly Known As
Novo Industri
Year Founded
1923
Service Provider Type
Lender
Primary Office
  • Novo Allé 1
  • 2880 Bagsvaerd
  • Denmark
+45 44 00 00 00

Novo Nordisk Financings

Company Name Financing Date Debt/Deal Date Debt/Deal Amount
Aerocrine Jun 2015 00000 0000000
Aerocrine Apr 2013 00000 0000000
To view Novo Nordisk’s complete services to companies history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novo Nordisk Co-Lenders (1)

Lender Lender Type Lender Location Total Shared Financings Last Shared Financing
OrbiMed Lender New York, NY 1 000.00
To view Novo Nordisk’s complete co-lenders history, request access »

Novo Nordisk Investment Preferences

Preferred Industries Preferred Verticals Preferred Deal Types Geographic Preferences Transaction Amount

This information is available in the PitchBook Platform. To explore Novo Nordisk‘s full profile, request access.

Request a free trial

Novo Nordisk Team (61)

Name Title Related Financings Office Contact
Info
Lars Jørgensen President & Chief Executive Officer 0 Bagsvaerd, Denmark
Karsten Knudsen Chief Financial Officer & Executive Vice President Bagsvaerd, Denmark
Marcus Schindler Ph.D Executive Vice President, Research & Early Development and Chief Scientific Officer 0 Bagsvaerd, Denmark
Anna Christensen Investor Relations Coordinator Bagsvaerd, Denmark
Michael Hoffman Vice President of Strategy and Innovation & Senior Director Strategic Execution & Operations - Market Access Bagsvaerd, Denmark
You’re viewing 5 of 61 team members. Get the full list »

Novo Nordisk Board Members (26)

Name Representing Role Since
Andreas Fibig Self Member of the Board of Directors and Member of the Research & Development Committee 000 0000
Christina Law Novo Nordisk Board Member & Member of the Audit Committee 000 0000
Elisabeth Christensen Novo Nordisk Board Member & Member of the Remuneration Committee 000 0000
Helge Lund Self Chair of the Board of Directors & Member of the Chair Committee and the Nomination Committee 000 0000
Henrik Poulsen Self Vice Chair of the Board of Directors, Member of the Chair Committee, Audit Committee and the Remuneration Committee 000 0000
You’re viewing 5 of 26 board members. Get the full list »

Novo Nordisk Subsidiaries (7)

Company Name Industry Location Founded
Embark Biotech Drug Discovery Copenhagen, Denmark 2017
Inversago Pharma Drug Discovery Montreal, Canada 0000
Staten Biotechnology Biotechnology Nijmegen, Netherlands 0000
Dicerna Pharmaceuticals Pharmaceuticals Lexington, MA 0000
Forma Therapeutics Drug Discovery Watertown, MA 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »